This month saw FemTech focused funds, multi-million-pound investments and corporate partnerships within the FemTech space. So we’re bringing you the latest market insights from expert advisors in investment, digital health and technology.
Green Flags for Investment – Dr Jane Van Dis said that “a founder team that understands its competitive landscape and is dedicated to the mission of improving womens’ lives” would always be a sure bet investment.
Gender Gap in Finance – Anna-Sophie Hartvigsen, co-founder of Female Invest, said “the frustrating thing about the gender gap in finance is that many of the underlying causes are rooted in systemic issues. However, the one area women can impact themselves (today) is how they manage their money.”
The global home insemination market size is forecast to reach $2.3 billion by 2025, growing at a CAGR of 6.8% during the forecast period 2020-2025.
The Women’s Health Diagnostics Market is Projected to Reach $36.6 billion by 2025.
The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and sexual health and pleasure, announced that Shannon Lovgren will join as Managing Director effective April 1, 2021.
Frost & Sullivan identified five critical success factors for the FemTech market to thrive.
Bellabeat launch $10 million fund to bring more attention to postnatal depression as well as incentivize institutes, companies, and clinics in the space to look for viable, holistic health solutions regarding the issue that is postnatal depression.
Healthy Pleasure Group (HPG), the global outfit dedicated solely to Sexual Health and Technology launches Amboy Street Ventures (ASV), the world’s first venture capital fund currently in the market focused on Sexual Health (for all genders) and Women’s Health Technology start-ups.